1. P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA. (23rd June 2022) Authors: Kuykendall, A.; Kremyanskaya, M.; Ginsburg, Y.; Pemmaraju, N.; Ritchie, E.; Gotlib, J.; Valone, F.; Khanna, S.; Gupta, S.; Hoffman, R.; Verstovsek, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗